Search filters

List of works by Thomas S K Gilbert

Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth

scientific article published on 09 May 2018

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer

scientific article published on 16 July 2019

BIRC6 mediates imatinib resistance independently of Mcl-1.

scientific article

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

scientific article published on 15 July 2021

Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma

scientific article published on 21 December 2018

Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology

scientific article published on 20 September 2019

EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

scientific article published on 01 August 2018

Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent manner.

scientific article published on 14 July 2017

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

scientific article published on 01 November 2018

Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.

scientific article

Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

scientific article published in 2022

Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues

scientific article published on 01 May 2019

Probing the global kinome and phosphoproteome in Chlamydomonas reinhardtii via sequential enrichment and quantitative proteomics

scientific article published on 27 September 2016

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition

scientific article published on 01 June 2021

The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer

scientific article published on 22 October 2021

Paulina is supported by:

About Paulina

Help